HemoSense to Supply LabCorp(R) with INRatio System.SAN JOSE San Jose, city, United States San Jose (sănəzā`, săn hōzā`), city (1990 pop. 782,248), seat of Santa Clara co., W central Calif.; founded 1777, inc. 1850. , Calif. -- HemoSense, Inc. (AMEX AMEX See: American Stock Exchange :HEM) today announced that it has signed an agreement with Laboratory Corporation of America([R]) Holdings (LabCorp([R])) (NYSE NYSE See: New York Stock Exchange :LH) to supply the HemoSense portable INRatio[R] PT/INR monitoring system to identified LabCorp laboratories. The INRatio system will also be made available to selected LabCorp patient service centers and affiliated physician offices nationwide. HemoSense's INRatio system consists of a small, portable meter and disposable test strips that provide a quick and accurate measurement of blood-clotting time, known as a PT/INR value. This test helps patients reduce the risk of strokes through frequent monitoring of anticoagulation therapy. "We are delighted to be working with a recognized laboratory leader, and this agreement with LabCorp is one more step toward our goal of increasing the HemoSense share of a growing market in patient blood coagulation monitoring," said Timothy Still, executive VP and chief commercial officer of HemoSense. "Monitoring patients' PT/INR levels at the point-of-care can help improve the treatment, health and lifestyle of patients taking warfarin warfarin (wôr`fərĭn), anticoagulant used to treat blood clots. In large doses it causes bleeding. Warfarin, mixed with bait, is used in rodent control. warfarin Anticoagulant drug, marketed as Coumadin. ." According to the U.S. Centers for Medicare & Medicaid Services (CMS (1) See content management system and color management system. (2) (Conversational Monitor System) Software that provides interactive communications for IBM's VM operating system. ), monthly blood coagulation testing is inadequate for the majority of patients on chronic warfarin therapy. HemoSense's INRatio system reduces the time and inconvenience required to manage warfarin and allows patients to play an active role in management of their warfarin dosage, encouraging optimal patient compliance, more time spent within the patient's therapeutic range and immediate dose management. The INRatio system is based on a reliable proprietary electrochemical electrochemical /elec·tro·chem·i·cal/ (-kem´i-k'l) pertaining to interaction or interconversion of chemical and electrical energies. e·lec·tro·chem·i·cal adj. technology that generates rapid PT/INR results simultaneously with two levels of quality control from a single drop of blood. Patient training is straightforward and test strips can be stored at room temperature for up to one year. Tests performed using the INRatio system in the point-of-care setting are currently reimbursed by Medicare and private payers for all patients on warfarin. The INRatio system is sold through a prestigious and growing network of distributors in the U.S. and internationally in 23 countries. About HemoSense HemoSense is a point-of-care diagnostic healthcare company that develops, manufactures and markets easy-to-use, handheld blood coagulation systems for monitoring patients taking warfarin. The HemoSense INRatio system, used by healthcare professionals and patients themselves, consists of a small monitor and disposable test strips. It provides accurate and convenient measurement of blood clotting blood clotting, process by which the blood coagulates to form solid masses, or clots. In minor injuries, small oval bodies called platelets, or thrombocytes, tend to collect and form plugs in blood vessel openings. time, or PT/INR values. Routine measurements of PT/INR are necessary for the safe and effective management of the patient's warfarin dosing. INRatio is sold in the United States and internationally. For more information, visit www.hemosense.com. About LabCorp([R]) Laboratory Corporation of America([R]) Holdings (LabCorp([R])), a S&P 500 company, is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $3.6 billion in 2006, over 25,000 employees nationwide, and more than 220,000 clients, LabCorp offers clinical assays ranging from routine blood analyses to HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. and genomic testing. LabCorp combines its expertise in innovative clinical testing technology with its Centers of Excellence: The Center for Molecular Biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller and Pathology, in Research Triangle Park Research Triangle Park, research, business, medical, and educational complex situated in central North Carolina. It has an area of 6,900 acres (2,795 hectares) and is 8 × 2 mi (13 × 3 km) in size. Named for the triangle formed by Duke Univ. , NC; National Genetics Institute, Inc. in Los Angeles, CA; ViroMed Laboratories, Inc. based in Minneapolis, MN; The Center for Esoteric Testing in Burlington, NC; DIANON Systems, Inc. based in Stratford, CT; US LABS based in Irvine, CA; and Esoterix and its Colorado Coagulation coagulation (kōăg'y  lā`shən), the collecting into a mass of minute particles of a solid dispersed throughout a liquid (a sol), usually followed by the precipitation or , Endocrine Sciences, and
Cytometry Associates laboratories. LabCorp clients include physicians,
government agencies, managed care organizations, hospitals, clinical
labs, and pharmaceutical companies. To learn more about LabCorp, visit
www.LabCorp.com.
HemoSense[R] and INRatio[R] are registered trademarks of HemoSense, Inc. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion